Počet záznamov: 1
First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2,251 patients
- First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2,251 patients . Onkológia. - ISSN 1336-8176 . - Roč. 6, č. 5 (2011), s. 311
- C 3069
článok
Počet záznamov: 1